Lineage Cell Therapeutics Inc banner
L

Lineage Cell Therapeutics Inc
TASE:LCTX

Watchlist Manager
Lineage Cell Therapeutics Inc
TASE:LCTX
Watchlist
Price: 475.2 ILS -4.04% Market Closed
Market Cap: ₪375.8m

Intrinsic Value

The intrinsic value of one LCTX stock under the Base Case scenario is 594.95 ILS. Compared to the current market price of 475.2 ILS, Lineage Cell Therapeutics Inc is Undervalued by 20%.

LCTX Intrinsic Value
594.95 ILS
Undervaluation 20%
Intrinsic Value
Price
L
Worst Case
Base Case
Best Case

Valuation History
Lineage Cell Therapeutics Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about LCTX?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is LCTX valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Lineage Cell Therapeutics Inc.

Explain Valuation
Alternatives to LCTX

Wall St
Price Targets

Dividends

Lineage Cell Therapeutics Inc
does not pay dividends
Shareholder Yield

Competitive Landscape

Ownership

LCTX Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one LCTX stock?

The intrinsic value of one LCTX stock under the Base Case scenario is 594.95 ILS.

Is LCTX stock undervalued or overvalued?

Compared to the current market price of 475.2 ILS, Lineage Cell Therapeutics Inc is Undervalued by 20%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett